{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T22:48:25Z","timestamp":1782773305296,"version":"3.54.5"},"reference-count":39,"publisher":"SAGE Publications","issue":"5","license":[{"start":{"date-parts":[[2022,9,9]],"date-time":"2022-09-09T00:00:00Z","timestamp":1662681600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Ann Pharmacother"],"published-print":{"date-parts":[[2023,5]]},"abstract":"<jats:p>At least 30 mL\/kg of crystalloid fluid administration within the first 3 hours of resuscitation is suggested by the current Surviving Sepsis Campaign guidelines for management of sepsis and septic shock. This commentary discusses the challenges with using a weight-based approach to bolus fluid dosing during the early phase of resuscitation of adult, obese patients. Based on the available literature, arguments can be made for the use of either ideal or adjusted body weight for weight-based fluid dosing, but there are concerns with fluid overload if using actual body weight to dose patients with more severe forms of obesity.<\/jats:p>","DOI":"10.1177\/10600280221125169","type":"journal-article","created":{"date-parts":[[2022,9,10]],"date-time":"2022-09-10T01:23:30Z","timestamp":1662773010000},"page":"609-616","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":2,"title":["Challenges With Using a Weight-Based Approach to Bolus Fluid Dosing in Obese Critically Ill Patients"],"prefix":"10.1177","volume":"57","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8909-9921","authenticated-orcid":false,"given":"Brian L.","family":"Erstad","sequence":"first","affiliation":[{"name":"Department of Pharmacy Practice &amp; Science, The University of Arizona, Tucson, AZ, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey F.","family":"Barletta","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Practice, College of Pharmacy, Midwestern University, Glendale, AZ, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2022,9,9]]},"reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-017-1909-5."},{"key":"e_1_3_2_3_2","unstructured":"Centers for Disease Control and Prevention. Defining adult overweight & obesity. Date unknown. Accessed June 20 2022. https:\/\/www.cdc.gov\/obesity\/basics\/adult-defining.html."},{"key":"e_1_3_2_4_2","first-page":"39","article-title":"Blood volume, cardiac output, and distribution of systemic blood flow in extreme obesity","volume":"1","author":"Alexander JK","year":"1962","unstructured":"Alexander JK, Dennis EW, Smith WG, Amad KH, Duncan WC, Austin RC. Blood volume, cardiac output, and distribution of systemic blood flow in extreme obesity. Cardiovasc Res Cent Bull. 1962;1:39-44.","journal-title":"Cardiovasc Res Cent Bull"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.56.4.605."},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1381\/096089206777346673."},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1007\/s12630-014-0218-6."},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1177\/1060028020907084."},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-019-2369-x."},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-019-2534-2."},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0907118."},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0000000000004864."},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.ccm.0000117317.18092.e4."},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.CCM.0000298158.12101.41."},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0b013e3181cb0cdc."},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0000000000002255."},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0000000000005337."},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13613-020-00679-3."},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-015-3850-x."},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa010307."},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1404380."},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1401602."},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1500896."},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0000000000003960."},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa062200."},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1101549."},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2017.10913."},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0000000000003779."},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.annemergmed.2018.03.039."},{"key":"e_1_3_2_30_2","unstructured":"National Heart Lung and Blood Institute. NHLBI PETAL Network ends Phase 3 sepsis trial early. Date unknown. https:\/\/www.nhlbi.nih.gov\/news\/2022\/nhlbi-petal-network-ends-phase-3-sepsis-trial-early."},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2202707."},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1111\/acem.14546."},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1186\/cc12680."},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1097\/TA.0b013e3181caab6c."},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcrc.2017.08.025."},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajem.2021.06.036."},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcrc.2020.09.006."},{"key":"e_1_3_2_38_2","doi-asserted-by":"publisher","DOI":"10.1177\/0885066620973917."},{"key":"e_1_3_2_39_2","unstructured":"Specifications Manual for National Hospital Inpatient Quality Measures. National hospital inpatient quality reporting measures specifications manual release notes (Version 5.8). Accessed September 6 2022. https:\/\/qualitynet.cms.gov\/inpatient\/specifications-manuals#tab6."},{"key":"e_1_3_2_40_2","doi-asserted-by":"publisher","DOI":"10.21037\/jtd.2019.12.84."}],"container-title":["Annals of Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/10600280221125169","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/10600280221125169","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/10600280221125169","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T11:17:06Z","timestamp":1777375026000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/10600280221125169"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,9]]},"references-count":39,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["10.1177\/10600280221125169"],"URL":"https:\/\/doi.org\/10.1177\/10600280221125169","relation":{},"ISSN":["1060-0280","1542-6270"],"issn-type":[{"value":"1060-0280","type":"print"},{"value":"1542-6270","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,9]]}}}